Publications by authors named "L Lichtenstein"

How cardiovascular activity interacts with lipid homeostasis is incompletely understood. We postulated a role for blood flow acting at endothelium in lipid regulatory organs. Transcriptome analysis was performed on livers from mice engineered for deletion of the flow-sensing PIEZO1 channel in endothelium.

View Article and Find Full Text PDF

Disparities in data underlying clinical genomic interpretation is an acknowledged problem, but there is a paucity of data demonstrating it. The All of Us Research Program is collecting data including whole-genome sequences, health records, and surveys for at least a million participants with diverse ancestry and access to healthcare, representing one of the largest biomedical research repositories of its kind. Here, we examine pathogenic and likely pathogenic variants that were identified in the All of Us cohort.

View Article and Find Full Text PDF

The Research Program's Data and Research Center (DRC) was established to help acquire, curate, and provide access to one of the world's largest and most diverse datasets for precision medicine research. Already, over 500,000 participants are enrolled in , 80% of whom are underrepresented in biomedical research, and data are being analyzed by a community of over 2,300 researchers. The DRC created this thriving data ecosystem by collaborating with engaged participants, innovative program partners, and empowered researchers.

View Article and Find Full Text PDF
Article Synopsis
  • Vaccines play a crucial role in controlling the COVID-19 pandemic, but patients with inflammatory bowel diseases (IBDs) on anti-TNF-α treatments show weaker immune responses after vaccinations.
  • A study involving 319 participants found that while a third dose of the Pfizer/BioNTech vaccine led to significant antibody levels in all groups, those on anti-TNF-α therapies experienced a drop in these levels three months later.
  • Despite no significant adverse effects or disease flare-ups, the lower antibody response after the third dose indicates a potential risk for infections, suggesting that a fourth dose might be necessary for this population.
View Article and Find Full Text PDF